2024 年 40 巻 2 号 p. 109-115
Cervical pregnancy is rare and represents approximately 1% of all ectopic pregnancies. We retrospectively examined the medical records of five cervical pregnancy cases between 2014 and 2022. One patient underwent Uterine Artery Embolization (UAE) due to heavy bleeding during follow-up without diagnosis of cervical pregnancy, one patient underwent local MTX injection therapy, one patient underwent hysteroscopic surgery due to insufficient decrease in hCG level after local MTX injection therapy, and two patients underwent UAE with cervical curettage. MTX therapy and cervical curettage following UAE preserved the uterus in all cases. Surgical intervention, including hysteroscopic surgery, should be considered early in cases of prolonged MTX therapy. Cervical curettage following UAE is an effective treatment that reduces the risk of massive bleeding and shortens the hospital stay. However, the risk of subsequent pregnancy complications must be considered for determining the indication